From: Emerging roles of circular RNAs in tumorigenesis, progression, and treatment of gastric cancer
No | Drugs or Microorganisms | CircRNA | Expression | Property in GC tumorigenesis or progression | Molecular mechanism | Refs. |
---|---|---|---|---|---|---|
1 | Lidocaine | circ_ANO5 | Downregulated | Repressor | Sponge miR-21-5p to upregulate LIFR | [99] |
2 | Astragaloside IV | circDLST | Upregulated | Enhancer | Sponge miR-489-3p to upregulate EIF4A1 | [104] |
3 | Icariin | hsa_circ_0003159 | Downregulated | Repressor | Sponge miR-223-3p to upregulate NLRP3 | [105] |
4 | Sinomenine | circTRPM7 | Upregulated | Enhancer | sponge miR-145-5p to upregulate PBX3 | [107] |
5 | Berberine | 31 circRNAs | Upregulated (19), Downregulated (12) | – | – | [111] |
6 | H. pylori | circMAN1A2 | Upregulated | Enhancer | Sponge miR-1236-3p to upregulate MTA2 | [116] |
7 | H. pylori | circFNDC3B | Upregulated | Enhancer | Sponge miR-942 to upregulate CD44 and miR-510 to upregulate CDH1 | [117] |
8 | H. pylori | circRNA_15430 | Downregulated | Repressor | Sponge miR-382-5p to downregulate ZCCHC14 | [118] |